Aggressive LDL-C-lowering therapy for non-culprit intermediate stenosis in ACS appears to promote plaque stabilization and improve coronary flow.
No takes yet. Share an insight, caveat, or question.
Kakehi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: